Rapid Relapse Marks a Distinct, High-Risk Group in Triple-Negative Breast Cancer
A Swedish nationwide registry study of 8,298 triple-negative breast cancer patients finds that relapse or death within 24 months defines ...
A Swedish nationwide registry study of 8,298 triple-negative breast cancer patients finds that relapse or death within 24 months defines ...
A study of 222 breast cancer patients found CT83 expression in nearly half of tumors, with its ties to aggressive ...
In a groundbreaking advance for oncology and personalized cancer therapy, the European GAMBIT study unravels critical insights into the risk ...
A recent cross-sectional study has brought to light disturbing racial and ethnic disparities in the presentation and treatment of de ...
In a groundbreaking study published in the British Journal of Cancer, researchers have unveiled critical insights into the mechanisms driving ...
Scientists at HSE University have unveiled a pivotal molecular mechanism underpinning the aggressive nature of triple-negative breast cancer (TNBC), a ...
In a groundbreaking study, researchers have harnessed the power of multi-omics profiling to delve deep into the molecular complexities of ...
In a groundbreaking study on triple-negative breast cancer (TNBC), researchers have unveiled a promising therapeutic strategy that could reshape how ...
In a groundbreaking study set to redefine therapeutic strategies for aggressive breast cancers, researchers have unveiled the pivotal role of ...
In a groundbreaking advancement that could revolutionize treatment paradigms for triple-negative breast cancer (TNBC), researchers have unveiled a novel nanotechnology-based ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine